Heparin-Induced Thrombocytopenia
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
HIT is characterized by a platelet-count fall of more than 50% at 5 to 10 days after the start of heparin and hypercoagulability. Platelet factor 4–heparin antibody testing has a high negative, but low positive, predictive value. Treatment involves therapeutic-dose anticoagulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Temporal Aspects of Heparin-Induced Thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441704 · Cited by 977
Impact of the patient population on the risk for heparin-induced thrombocytopenia
Warkentin, T. E., Sheppard, J.-A. I., Horsewood, P., Simpson, P. J., Moore, J. C., & Kelton, J. G. (2000) · Blood · doi:10.1182/blood.v96.5.1703 · Cited by 924
A 14-year study of heparin-induced thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00258-6 · Cited by 886
Martel, N., Lee, J., & Wells, P. S. (2005) · Blood · doi:10.1182/blood-2005-04-1546 · Cited by 875
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Warkentin, T. E., Greinacher, A., Koster, A., & Lincoff, A. M. (2008) · Chest · doi:10.1378/chest.08-0677 · Cited by 816
Self-citationHeparin-induced thrombocytopenia: laboratory studies
Kelton, J., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., & Murphy, W. (1988) · Blood · doi:10.1182/blood.v72.3.925.925 · Cited by 483
Cuker, A., Gimotty, P. A., Crowther, M. A., & Warkentin, T. E. (2012) · Blood · doi:10.1182/blood-2012-07-443051 · Cited by 479
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Warkentin, T. E., & Kelton, J. G. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00009 · Cited by 467
CUKER, A., AREPALLY, G., CROWTHER, M. A., RICE, L., DATKO, F., HOOK, K., PROPERT, K. J., KUTER, D. J., ORTEL, T. L., KONKLE, B. A., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04059.x · Cited by 257
Goel, R., Ness, P. M., Takemoto, C. M., Krishnamurti, L., King, K. E., & Tobian, A. A. R. (2015) · Blood · doi:10.1182/blood-2014-10-605493 · Cited by 240
Guidelines on the diagnosis and management of heparin‐induced thrombocytopenia: second edition
Watson, H., Davidson, S., & Keeling, D. (2012) · British Journal of Haematology · doi:10.1111/bjh.12059 · Cited by 232
A Comparison of Danaparoid and Lepirudin in Heparin-induced Thrombocytopenia
Farner, B., Eichler, P., Kroll, H., & Greinacher, A. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615946 · Cited by 192
Self-citationStudies of the immune response in heparin-induced thrombocytopenia
Warkentin, T. E., Sheppard, J.-A. I., Moore, J. C., Cook, R. J., & Kelton, J. G. (2009) · Blood · doi:10.1182/blood-2008-10-186064 · Cited by 180
Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia
Rauova, L., Hirsch, J. D., Greene, T. K., Zhai, L., Hayes, V. M., Kowalska, M. A., Cines, D. B., & Poncz, M. (2010) · Blood · doi:10.1182/blood-2010-03-276964 · Cited by 166
Jaax, M. E., Krauel, K., Marschall, T., Brandt, S., Gansler, J., Fürll, B., Appel, B., Fischer, S., Block, S., Helm, C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478966 · Cited by 162
Self-citationChong, B. H., Cade, J. F., Magnani, H., Manoharan, A., Oldmeadow, M., Arthur, C., Rickard, K., Gallo, J., Lloyd, J., Seshadri, P., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616046 · Cited by 159
Warkentin, T. E., Basciano, P. A., Knopman, J., & Bernstein, R. A. (2014) · Blood · doi:10.1182/blood-2014-01-549741 · Cited by 158
Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia
Ziporen, L., Li, Z. Q., Park, K. S., Sabnekar, P., Liu, W. Y., Arepally, G. M., Shoenfeld, Y., Kieber‐Emmons, T., Cines, D. B., & Poncz, M. (1998) · Blood · doi:10.1182/blood.v92.9.3250 · Cited by 145
Kang, M. S., Alahmadi, M. D., Sawh, S. C., Kovacs, M. J., & Lazo‐Langner, A. (2014) · Blood · doi:10.1182/blood-2014-09-599498 · Cited by 134
Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes
Krauel, K., Weber, C., Brandt, S. V., Zähringer, U., Mamat, U., Greinacher, A., & Hammerschmidt, S. (2012) · Blood · doi:10.1182/blood-2012-06-434985 · Cited by 130
Self-citationHeparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes
Warkentin, T. E., & Greinacher, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902778180 · Cited by 121
Self-citationKrauel, K., Hackbarth, C., Fürll, B., & Greinacher, A. (2011) · Blood · doi:10.1182/blood-2011-05-353391 · Cited by 116
Self-citationKasthuri, R. S., Glover, S. L., Jonas, W. S., et al. (2012) · Blood · doi:10.1182/blood-2011-06-359430 · Cited by 114
Warkentin, T. E., Sheppard, J. I., Chu, F. V., Kapoor, A., Crowther, M. A., & Gangji, A. S. (2014) · Blood · doi:10.1182/blood-2014-07-590844 · Cited by 99
Warkentin, T. E., & Sheppard, J. I. (2014) · Blood · doi:10.1182/blood-2013-10-533083 · Cited by 94
Brandt, S. V., Krauel, K., Gottschalk, K. E., Renné, T., Helm, C. A., Greinacher, A., & Block, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0634 · Cited by 84
Self-citationCritical role for mouse marginal zone B cells in PF4/heparin antibody production
Zheng, Y., Yu, M., Podd, A., Yuan, L., Newman, D. K., Wen, R., Arepally, G. M., & Wang, D. (2013) · Blood · doi:10.1182/blood-2013-01-477091 · Cited by 71
Me or not me? The danger of spontaneity
Greinacher, A. (2014) · Blood · doi:10.1182/blood-2014-04-566836 · Cited by 41
Self-citation
Cited by
Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2104840 · Cited by 2,259
Self-citation2021 ELSO Adult and Pediatric Anticoagulation Guidelines
McMichael, A. B. V., Ryerson, L. M., Ratano, D., Fan, E., Faraoni, D., & Annich, G. M. (2022) · ASAIO Journal · doi:10.1097/mat.0000000000001652 · Cited by 437
Autoimmune heparin‐induced thrombocytopenia
Greinacher, A., Selleng, K., & Warkentin, T. E. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13813 · Cited by 406
Self-citationAdenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Mendonça, S. A., Lorincz, R., Boucher, P., & Curiel, D. T. (2021) · npj Vaccines · doi:10.1038/s41541-021-00356-x · Cited by 294
The therapeutic age of the neonatal Fc receptor
Pyzik, M., Kozicky, L. K., Gandhi, A. K., & Blumberg, R. S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00821-1 · Cited by 288
Metadata
- Authors
- Greinacher, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-07-16
- Volume
- 373
- Issue
- 3
- Pages
- 252-261
- ISSN
- 0028-4793
- 1533-4406
- OpenAlex
- W2911131326
- Cited by
- 608
- References
- 30
- FWCI
- 56.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.